The 2011 Leading Animal Health Companies R&D Expenditures and Major Programs

Venture Planning Group (VPG), January 2010, Pages: 75

Each company analysis provides:<ul><li>Estimated R&D budget.</li><li>Research facilities and staff.</li><li>New technologies, products and applications in R&D, including their development phase and introduction dates.</ul><li>The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly, Fort Dodge/Wyeth, Merial, Novartis, Pfizer, Schering-Plough and Virbac.Contains 75 pages

Customers who bought this item also bought

• The 2011 US Blood Banking Market
• Global Animal Health Market: Emerging Markets Driving Growth
• R&D Cost Cutting: Managing Cost Containment and Safeguarding Productivity
• The 2011 US Coagulation Market
• The 2011 Italian Blood Banking Market
• The 2011 French Blood Banking Market
• The 2011 UK Blood Banking Market
• The 2011 Japanese Blood Banking Market
• The 2011 Spanish Blood Banking Market
• The 2011 German Blood Banking Market